Oasmia Pharmaceutical Ab Revenue Growth Rates (OASM), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Oasmia Pharmaceutical Ab  (OASM)
 

OASM's Revenue Growth by Quarter and Year

Oasmia Pharmaceutical Ab's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OASM Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
4th Quarter December 3.17
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 3.17





OASM Revenue fourth quarter 2018 Y/Y Growth Comment
Oasmia Pharmaceutical Ab in the fourth quarter 2018 achieved Revenue of $ 3.17 millions compare to recorded in same quarter a year ago.

According to the results reported in the fourth quarter 2018, Oasmia Pharmaceutical Ab achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Oasmia Pharmaceutical Ab' s Revenue no change of 0% ranks overall at the positon no. in the fourth quarter 2018.


OASM Revenue ( Y/Y Growth %) 2018
 2017 2016 2015
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Oasmia Pharmaceutical Ab's fourth quarter 2018 Revenue $ 3.17 millions OASM's Income Statement
Oasmia Pharmaceutical Ab's fourth quarter 2017 Revenue $ 0.00 millions Quarterly OASM's Income Statement


OASM Revenue (Quarter on Quarter Growth %)

 2018
 2017 2016 2015
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Back to OASM Growth rate Comparisons >> Back to OASM Growth rate Comparisons >>


Revenue fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Oasmia Pharmaceutical Ab's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OASM's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OASM's IV. Quarter Q/Q Revenue Comment


Oasmia Pharmaceutical Ab's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
 12 Months Ending
 12 Months Ending
 12 Months Ending
 12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the period, Oasmia Pharmaceutical Ab's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Oasmia Pharmaceutical Ab achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the period, Oasmia Pharmaceutical Ab's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Oasmia Pharmaceutical Ab achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OASM's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Apr 30 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Apr 30 2018
Zimmer Biomet Holdings Inc -0.16%$ -0.159 millions
Tg Therapeutics Inc -0.25%$ -0.249 millions
Hanger inc.-0.31%$ -0.309 millions
Surgalign Holdings Inc -0.55%$ -0.546 millions
3m Company-0.56%$ -0.563 millions
Bio rad Laboratories Inc -0.72%$ -0.717 millions
Quest Diagnostics Inc-1.39%$ -1.394 millions
Biomarin Pharmaceutical Inc-1.42%$ -1.421 millions
Inspiremd Inc -1.44%$ -1.439 millions
Star Equity Holdings Inc -1.46%$ -1.459 millions
Prophase Labs Inc -1.47%$ -1.470 millions
Meridian Bioscience Inc -1.54%$ -1.536 millions
Sonida Senior Living Inc -1.60%$ -1.601 millions
Hca Healthcare Inc -1.78%$ -1.784 millions
Immune Design Corp.-1.86%$ -1.856 millions
Bausch Health Companies Inc -1.94%$ -1.942 millions
Opiant Pharmaceuticals Inc -2.21%$ -2.211 millions
Htg Molecular Diagnostics Inc-2.23%$ -2.227 millions
Invacare Holdings Corporation-2.31%$ -2.307 millions
Pediatrix Medical Group Inc -2.46%$ -2.458 millions
Gilead Sciences Inc -2.59%$ -2.589 millions
Dentsply Sirona Inc -2.87%$ -2.869 millions
Diversicare Healthcare Services Inc -3.26%$ -3.258 millions
Encision Inc -3.33%$ -3.326 millions
Orasure Technologies Inc-3.43%$ -3.425 millions
Alphatec Holdings Inc -3.58%$ -3.576 millions
Stereotaxis Inc -3.81%$ -3.806 millions
Sophiris Bio Inc.-3.85%$ -3.846 millions
Kaya Holdings Inc -4.21%$ -4.206 millions
Utah Medical Products Inc-4.36%$ -4.362 millions


About Oasmia Pharmaceutical Ab Revenue Growth Rates (OASM), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.